Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims
NEW BRUNSWICK, N.J., October 14, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that LTL Management LLC (LTL), a newly created and separate subsidiary of Johnson & Johnson, that was established to hold and manage claims in the cosmetic talc litigation, has filed for voluntary Chapter 11 bankruptcy protection. This filing is intended to resolve all claims related to cosmetic talc in a manner that is equitable to all parties, including any current and future claimants. Johnson & Johnson and its other affiliates did not file for bankruptcy protection and will continue to operate their bus...
Source: Johnson and Johnson - October 14, 2021 Category: Pharmaceuticals Tags: Latest News Source Type: news

Why a One-Size-Fits-All Approach to Breast Cancer Prevention Can Leave Women Vulnerable
When Heather Mann learned she had breast cancer, it was a complete surprise. “I had never thought that I was at high risk for breast cancer,” the 49-year-old says. “I don’t have any family lineage or history of breast cancer. My grandmother on my father’s side had breast cancer, but apparently that’s not usually a significant factor. So I was very surprised when I found out that I had a malignant tumor.” Shelia Bauer ‘s breast cancer journey took a very different route. After her twin sisters died of the disease in their 50s, Bauer, now 73, assumed that she likely carried som...
Source: TIME: Health - October 13, 2021 Category: Consumer Health News Authors: Time Tags: Uncategorized Cancer healthscienceclimate Source Type: news

Penn State team secures funding to develop wearable brain scanner
Researchers from Pennsylvania State University have been awarded a two-year...Read more on AuntMinnie.comRelated Reading: Photoacoustic US shows promise for visualizing lymphatic vessels Ultrasound + photoacoustic imaging spot prostate cancer New imaging method could boost ovarian cancer detection Group reveals work on hybrid acoustic-optical imaging Photoacoustic US offers option to thyroid biopsy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 12, 2021 Category: Radiology Source Type: news

Twitter mourns educator Dr. Nadia Chaudhri. What can be learned from her story?
Dr. Nadia Chaudhri, a neuroscientist and professor, shared her experience with ovarian cancer on Twitter, showing how social media can be a powerful tool to connect and educate on chronic or serious illnesses. (Source: mobihealthnews)
Source: mobihealthnews - October 11, 2021 Category: Information Technology Source Type: news

Unexpected Thrombocytosis Could Flag Occult Cancer Unexpected Thrombocytosis Could Flag Occult Cancer
Thrombocytosis that shows up in a routine blood test increases the risk for an imminent diagnosis of several typically'silent'cancers, such as pancreatic, ovarian, and cervical cancers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Ovarian cancer: The common pattern when peeing that can be a sign - what to look for
OVARIAN cancer symptoms can sometimes be hard to spot, and might be confused for other conditions. It is important to be aware of the signs, as the earlier ovarian cancer is diagnosed and treated, the better the chance of a cure. (Source: Daily Express - Health)
Source: Daily Express - Health - October 2, 2021 Category: Consumer Health News Source Type: news

‘Highly effective’ ovarian cancer treatment could help thousands of women
New drug combination shrunk tumours significantly in 46% of patients with treatment-resistant form of diseaseThousands of women withovarian cancer could benefit from a revolutionary drug combination after it was shown to shrink tumours in half of patients with an advanced form of the disease.The pair of drugs – which work together to block the signals cancer cells need to grow – could offer a new treatment option for women with a type of ovarian cancer that rarely responds to chemotherapy or hormone therapy.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 19, 2021 Category: Science Authors: Andrew Gregory Health editor Tags: Ovarian cancer Breast cancer Medical research Health Society Science Source Type: news

Cell therapy partnership between Bay Area biotechs offers hope to cancer patients
Imagine a world in which physicians can confidently cure cancer. Two Bay Area life sciences companies are working together to make this vision a reality. Atara Biotherapeutics Inc., founded in 2012, is developing a pipeline of cell therapies to treat various types of cancer and autoimmune diseases. Bayer is licensing Atara’s cutting-edge cell therapies that t arget certain types of aggressive tumors including mesothelioma, pancreatic, ovarian and non-small-cell lung cancer. “With cancer therapies,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 16, 2021 Category: Pharmaceuticals Authors: Lauren Lawley Head Source Type: news

Cancer symptoms: Seven signs of ovarian cancer - a cancer difficult to diagnose early
BEING the fifth leading cause of cancer death in women, targeting the early signs of ovarian cancer is vital in order to prevent the spread of the disease. However, this particular form of cancer has proven difficult for doctors to diagnose before it is too late. (Source: Daily Express - Health)
Source: Daily Express - Health - September 13, 2021 Category: Consumer Health News Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate can...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Consumer Health: Treating ovarian cancer
September is Ovarian Cancer Awareness Month, which makes this a good time to learn about treating ovarian cancer. Ovarian cancer ranks fifth in cancer deaths among women in the U.S., according to the American Cancer Society. More than 21,000 new cases will be diagnosed in the U.S. this year, and nearly 14,000 women will die of the disease. Early stage ovarian cancer rarely causes any symptoms. Advanced-stage ovarian cancer may cause few and nonspecific symptoms… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 1, 2021 Category: Databases & Libraries Source Type: news

Judge Moves Johnson & Johnson Closer to Potential Reorganization
Johnson & Johnson is closer to unloading its talc-related liabilities onto a new subsidiary that could subsequently declare Chapter 11 bankruptcy and dramatically alter the thousands of lawsuits the company is facing. A U.S. Bankruptcy Court judge in the District of Delaware declined requests last week from a panel of personal injury lawyers to prohibit Johnson & Johnson from exercising that option. J&J is facing more than 34,000 lawsuits that link its talc-based products to cancer, the majority of which are ovarian cancer. A small fraction of those lawsuits involve malignant mesothelioma. Most of the ...
Source: Asbestos and Mesothelioma News - August 31, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Roundup: ANDHealth receives $14M in gov't funding, Zhongchao launches ovarian cancer patient management platform and more briefs
Also, digital health firms in Myanmar and the Philippines are offering free virtual doctor consultations. (Source: mobihealthnews)
Source: mobihealthnews - August 27, 2021 Category: Information Technology Source Type: news

Mesothelioma Olaparib Clinical Trial Targets Genetic Mutation
The mesothelioma program at University of Chicago Medicine is recruiting patients for its latest clinical trial involving olaparib, an oral chemotherapy drug targeting cancer-driven genetic mutations. This single-center, phase II clinical trial is open to patients with either pleural mesothelioma or peritoneal mesothelioma. Olaparib, also known by the brand name Lynparza, works by repairing or controlling specific gene mutations. It is known as a protein inhibitor and has been approved by the U.S. Food and Drug Administration for use with breast and ovarian cancers. Mesothelioma, a rare malignancy caused by exposu...
Source: Asbestos and Mesothelioma News - August 24, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

This Breast Cancer Gene Is Less Well Known, but Nearly as Dangerous
PALB2 is not as well known as BRCA, but mutations of the gene can raise a woman ’s risk for breast cancer almost as much. (Source: NYT Health)
Source: NYT Health - August 17, 2021 Category: Consumer Health News Authors: Susan Berger Tags: your-feed-science Breast Cancer Genetics and Heredity Tests (Medical) Pancreatic Cancer Ovarian Cancer Women and Girls American College of Medical Genetics your-feed-healthcare Source Type: news

Nigeria: Protect Breastfeeding - Strengthening Workplace Policies for Exclusive Breastfeeding in Nigeria
[Nigeria Health Watch] Breastfeeding provides essential nutrients to newborns and infants, which translate to proper growth and development from childhood to adulthood. There are many benefits to breastfeeding for both infants and mothers. These include, a reduced risk of infections, heart disease, obesity and others, for the infant and a reduced risk of breast and ovarian cancers, heart disease, etc., for the mother. It also has future economic benefits for countries. Avoidable illnesses and deaths resulting from not breastfeed (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 12, 2021 Category: African Health Source Type: news

Using AI with CT helps predict breast cancer metastasis
Using a deep-learning algorithm with contrast-enhanced CT data is an effectiv...Read more on AuntMinnie.comRelated Reading: CT/ultrasound fusion enhances ovarian biopsies CT radiomics characterizes complex cystic renal lesions Deep learning gives a boost to CT image reconstruction CT shows manifestations of recreational drug use AI plus CT improves liver steatosis assessment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 6, 2021 Category: Radiology Source Type: news

J & J Facing Scrutiny from Congress, Black Women ’s Organization
Plaintiff attorneys and congressional leaders have renewed their push against Johnson & Johnson and its allegedly toxic, talc-based powder products, questioning motives and demanding answers, according to various media outlets. A committee of attorneys filed a restraining order in U.S. District Court in Wilmington, Delaware, July 27, hoping to prevent J&J’s potential plan to unload its talc-related liabilities on a new subsidiary that would subsequently file for bankruptcy. The next day, the U.S. House of Representatives Committee on Oversight and Reform delivered a letter to J&J’s chief execu...
Source: Asbestos and Mesothelioma News - August 2, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Black Women ’ s Group Sues Johnson & amp; Johnson Over Baby Powder
Lawsuit claims that J&J targeted baby powder ads to Black women despite knowing it contained ingredients that could cause ovarian cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 29, 2021 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Pharmacy, Institutional, Source Type: news

FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment
The U.S. Food and Drug Administration has granted orphan drug designation to ONCOFID-P for the treatment of malignant pleural mesothelioma, a step toward another potential therapy option for patients. ONCOFID-P is an innovative drug conjugate already in advanced clinical development for the treatment of invasive bladder cancer. The mesothelioma designation is based on preclinical data showing high antitumor activity in laboratory and mice models. Fidia Farmaceutici, a multinational research company based in Italy, announced the latest FDA designation, which is designed to encourage the development of novel drugs, par...
Source: Asbestos and Mesothelioma News - July 28, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

New organ-on-a-chip finds crucial interaction between blood, ovarian cancer tumors
(Texas A&M University) Researchers at Texas A&M University are pushing organ-on-a-chip devices to new levels that could change the way clinicians approach cancer treatment, particularly ovarian cancer. A team has recently submitted a patent disclosure with the Texas A&M Engineering Experiment Station. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 23, 2021 Category: Cancer & Oncology Source Type: news

Johnson & Johnson Weighs Options for Talc Liabilities
Johnson & Johnson is considering the creation of a new subsidiary to absorb its widespread asbestos liabilities, according to reports in The Wall Street Journal and other news outlets. The J&J subsidiary would then declare Chapter 11 bankruptcy, potentially saving the multinational corporation billions of dollars. Reuters News Service also reported the subsidiary possibility, citing unnamed personal injury attorneys who learned of the option while negotiating their current claims with J&J officials. A spokesperson for Johnson & Johnson would not confirm the reports.  “Johnson & J...
Source: Asbestos and Mesothelioma News - July 22, 2021 Category: Environmental Health Authors: Chris Elkins Source Type: news

ASCO Data Confirm Standard of Care for Cervical, Ovarian Cancer ASCO Data Confirm Standard of Care for Cervical, Ovarian Cancer
Dr Maurie Markman describes two large phase 3 trials that'clearly establish'the existing standard of care for cervical and ovarian cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 10, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Types of Ovarian Cancer Medications
Title: Types of Ovarian Cancer MedicationsCategory: Diseases and ConditionsCreated: 7/9/2021 12:00:00 AMLast Editorial Review: 7/9/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 9, 2021 Category: Cancer & Oncology Source Type: news

Oral Contraceptives Lower Ovarian Cancer Risk in BRCA Carriers
Findings seen in BRCA1 and BRCA2 mutation carriers; reduction greater with longer duration of use in BRCA1 carriers (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 7, 2021 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Oral Contraceptives Lower Ovarian Cancer Risk in BRCA Carriers
WEDNESDAY, July 7, 2021 -- Oral contraceptive use is associated with a reduced risk for ovarian cancer for BRCA mutation carriers, according to a study published in the July issue of the American Journal of Obstetrics& Gynecology. Lieske H.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 7, 2021 Category: Pharmaceuticals Source Type: news

Ovarian Stimulation Drugs Not Tied to Higher Breast Cancer Risk
THURSDAY, July 1, 2021 -- Women treated with ovarian stimulation drugs for infertility do not have a significantly increased risk of breast cancer, according to a systematic review and meta-analysis published in the July issue of Fertility and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 1, 2021 Category: Pharmaceuticals Source Type: news

World-first artificial intelligence study to map risks of ovarian cancer in women
(University of South Australia) The University of South Australia will lead a world-first study, using artificial intelligence, to map the risks of the most fatal reproductive cancer in women worldwide so it can be detected and treated earlier. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2021 Category: Cancer & Oncology Source Type: news

Ovarian Cancer Management: We Have Come So Far Ovarian Cancer Management: We Have Come So Far
Gynecologic oncologist Dr Shannon Westin considers how far ovarian cancer management has come since she was in medical school, and speaks to the areas that still need to be addressed.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 29, 2021 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health MDAngle Source Type: news

GPS Vaccine Plus Opdivo Shows Promise for Pleural Mesothelioma
A novel, targeted cancer vaccine combined with the immunotherapy drug Opdivo has shown surprising efficacy for mesothelioma patients whose disease no longer responds to standard chemotherapy. In a phase I clinical trial at Memorial Sloan Kettering Cancer Center, the galinpepimut-S vaccine, also known as GPS, has produced an impressive, anti-tumor synergy with Opdivo, based upon early data. GPS targets the WT1 protein, which is expressed in high levels of various cancers but rarely seen in normal adult cells. The protein has been especially resistant to standard chemotherapy. The vaccine works by inducing a powerfu...
Source: Asbestos and Mesothelioma News - June 29, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

What Are the Early Warning Signs of Ovarian Cancer?
Title: What Are the Early Warning Signs of Ovarian Cancer?Category: Diseases and ConditionsCreated: 6/29/2021 12:00:00 AMLast Editorial Review: 6/29/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 29, 2021 Category: Cancer & Oncology Source Type: news

Selection tool accurately predicts ovarian damage in girls with cancer
(European Society of Human Reproduction and Embryology) Cancer treatments can cause premature ovarian failure (POI) including in girls who want to become mothers eventually. Ovarian tissue cryopreservation (OTC) provides a future fertility option but is invasive, has risks and evidence indicates that most girls don't develop POI. So, doctors face the dilemma of how to offer OTC appropriately. An assessment tool has been found to help predict correctly which female cancer patients aged under 18 years will develop POI and should therefore be offered OTC. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 29, 2021 Category: International Medicine & Public Health Source Type: news

Oncotarget: Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells
(Impact Journals LLC) Support recently reported findings of clinical benefit when relacorilant is added to paclitaxel-containing therapy in patients with ovarian and pancreatic cancers and provide a new rationale for combining relacorilant with additional cytotoxic agents. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news

Fertility drugs used in IVF do NOT increase the risk of women developing breast cancer, study finds
There was no significant increase in the risk of breast cancer among women treated with any ovarian stimulation drug for infertility, say King's College London scientists. (Source: the Mail online | Health)
Source: the Mail online | Health - June 21, 2021 Category: Consumer Health News Source Type: news

ESMO Gynaecological Cancers Virtual Congress 2021
(European Society for Medical Oncology) The first edition of the ESMO Gynaecological Cancers Congress will be held as a virtual meeting on 25-26 June 2021 and will focus on ovarian cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news

CNN's Amanpour Being Treated for Ovarian Cancer CNN's Amanpour Being Treated for Ovarian Cancer
Christiane Amanpour, the chief international anchor for CNN, announced Monday at the start of her daily TV program that she's been diagnosed with ovarian cancer.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Health Highlights: June 15, 2021
Christiane Amanpour Reveals Ovarian Cancer Diagnosis After revealing that she's been diagnosed with ovarian cancer, CNN's chief international anchor Christiane Amanpour urged women to learn about and get regular cancer screenings. " I've had... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 15, 2021 Category: General Medicine Source Type: news

Model suggests surgery should precede chemotherapy for select patients with ovarian cancer
(NYU Langone Health / NYU Grossman School of Medicine) Certain patients with an aggressive form of ovarian cancer have a better chance of a cure through surgical removal of their tumor before chemotherapy instead of the reverse, a new study shows. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news

Researchers tout ovarian cancer alpha therapy at SNMMI 2021
New research in mice presented June 11 at the Society of Nuclear Medicine an...Read more on AuntMinnie.comRelated Reading: Niowave starts isotope production Niowave begins Mo-99 production in U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 11, 2021 Category: Radiology Source Type: news

FDA approves niraparib for first-line maintenance of advanced ovarian cancer
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves olaparib plus bevacizumab as maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancers
Hematology / Oncology Drug Approvals (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

How Long Live After Diagnosed with Ovarian Cancer
How Long Do You Live After Being Diagnosed with Ovarian Cancer? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 11, 2021 Category: General Medicine Source Type: news

Promising ovarian cancer treatment proves effective and efficient
(Society of Nuclear Medicine and Molecular Imaging) Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant to traditional therapies, the new radiopharmaceutical can be produced in 25 minutes at low cost, which leads to better efficiency compared with alternative methods. This research was presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 11, 2021 Category: International Medicine & Public Health Source Type: news

Oncotarget: Anti-hormonal treatment eligibility in granulosa cell tumors of the ovary
(Impact Journals LLC) Granulosa cell tumors are a well-defined ovarian cancer subtype, responsible for 2-5% of ovarian malignancies with an annual incidence of 0.6-1.0 per 100.000 women worldwide. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 9, 2021 Category: Cancer & Oncology Source Type: news

Drug Boosts Survival for Women With Advanced Ovarian Cancer
A recent study suggests that "maintenance therapy" with a targeted cancer drug may add years to some patients' lives. (Source: WebMD Health)
Source: WebMD Health - June 7, 2021 Category: Consumer Health News Source Type: news

Supreme Court rejects Johnson Johnson appeal challenging $2 billion talc verdict
(Natural News) The United States Supreme Court declined Tuesday, June 1, to take up an appeal by healthcare firm Johnson & Johnson that challenged a 2018 court ruling in favor of women who said they developed ovarian cancer from using some of the firm’s talcum powder products, leaving the verdict against the pharmaceutical giant intact.... (Source: NaturalNews.com)
Source: NaturalNews.com - June 7, 2021 Category: Consumer Health News Source Type: news

What Is Usually the First Sign of Ovarian Cancer
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2021 Category: General Medicine Source Type: news

J & J's Appeal Rejected by U.S. Supreme Court
The U.S. Supreme court said Tuesday that it won't hear Johnson & Johnson's appeal over a $2 billion ruling in favor of women who said they developed ovarian cancer from using the company's talc products. (Source: WebMD Health)
Source: WebMD Health - June 2, 2021 Category: Consumer Health News Source Type: news

J & J's Appeal in $2 Billion Verdict Rejected by U.S. Supreme Court
WEDNESDAY, June 2, 2021 -- The U.S. Supreme Court said Tuesday that it will not hear Johnson& Johnson's appeal over a $2 billion ruling in favor of women who said they developed ovarian cancer from using the company's talc products. The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 2, 2021 Category: Pharmaceuticals Source Type: news